Kyowa Kirin Co., Ltd.
https://www.kyowakirin.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Kyowa Kirin Co., Ltd.
Marching On: Eight Novel Agents Among March Goal Dates For US FDA
Crowded calendar could bring to an end the slow start for novel approvals in 2024, as decisions come due for Lilly’s donanemab, Merck’s sotatercept, Regeneron’s odronextamab and more.
As 2024 Begins, US FDA’s Novel Agent Prospects Look A Lot Like 2023
Immuno-oncology will remain a major force at both FDA’s drugs and biologics centers, but watch for psychiatry and antibiotics to make some noise; rare pediatric diseases will remain prominent as the priority review voucher program heads into the sunset.
The ‘Haves And Have-Nots’ Are Becoming Clearer In Cell And Gene Therapy
2023 saw a number of gene therapy companies go to the wall, but those that can combine clinical significance and commercial success can build sustainable businesses.
In Vivo’s Deals Of The Year: Cast Your Vote!
It is time for In Vivo's 16th annual Deals of the Year contest. We've selected 12 nominees across three categories – Top M&A, Top Alliance and Top Financing – and you get to pick the winners.
Company Information
- Industry
- Biotechnology
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
-
Pharmaceuticals
- Nutraceuticals
- Radiopharmaceuticals, Contrast Agents
-
Biotechnology
- Drug Discovery Tools
- Other Names / Subsidiaries
-
- Archimedes Pharma Ltd.
- Centus Biotherapeutics Ltd.
- Daiichi Fine Chemical Co., Ltd.
- Fujifilm Kyowa Kirin Biologics Co., Ltd.
- Kirin Pharma Company, Limited
- Kyowa Kirin Asia Pacific Pte. Ltd.
- Kyowa Kirin Australia Pty Ltd
- Kyowa Kirin International PLC
- Kyowa Pharma Chemical Co., Ltd.
- ProStrakan Group plc
- Kyowa Kirin
- Kyowa Kirin Frontier Co., Ltd.
- Kyowa Hakko Kirin (Singapore) Pte. Ltd.
- Kyowa Hakko Kirin Co., Ltd.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice